#+TITLE: Disorders of Sphingolipid Synthesis
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+DATE: \today

:PROPERTIES:
#+DRAWERS: PROPERTIES
#+LaTeX_CLASS: beamer
#+LaTeX_CLASS_OPTIONS: [presentation, smaller]
#+BEAMER_THEME: Ilmenau
#+BEAMER_COLOR_THEME: whale
#+BEAMER_FRAME_LEVEL: 2
#+COLUMNS: %40ITEM %10BEAMER_env(Env) %9BEAMER_envargs(Env Args) %4BEAMER_col(Col) %10BEAMER_extra(Extra)
#+OPTIONS: H:2 toc:nil
#+PROPERTY: header-args:R :session *R*
#+PROPERTY: header-args :cache no
#+PROPERTY: header-args :tangle yes
#+STARTUP: beamer
#+STARTUP: overview
#+STARTUP: hidestars
#+STARTUP: indent
# #+BEAMER_HEADER: \subtitle{Part 1: Maple Syrup Urine Diseas}
#+BEAMER_HEADER: \institute[NSO]{Newborn Screening Ontario | The University of Ottawa}
#+BEAMER_HEADER: \titlegraphic{\includegraphics[height=1cm,keepaspectratio]{../logos/NSO_logo.pdf}\includegraphics[height=1cm,keepaspectratio]{../logos/cheo-logo.png} \includegraphics[height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}}
#+latex_header: \hypersetup{colorlinks,linkcolor=white,urlcolor=blue}
#+LaTeX_header: \usepackage{textpos}
#+LaTeX_header: \usepackage{textgreek}
#+LaTeX_header: \usepackage[version=4]{mhchem}
#+LaTeX_header: \usepackage{chemfig}
#+LaTeX_header: \usepackage{siunitx}
#+LaTeX_header: \usepackage{gensymb}
#+LaTex_HEADER: \usepackage[usenames,dvipsnames]{xcolor}
#+LaTeX_HEADER: \usepackage[T1]{fontenc}
#+LaTeX_HEADER: \usepackage{lmodern}
#+LaTeX_HEADER: \usepackage{verbatim}
#+LaTeX_HEADER: \usepackage{tikz}
#+LaTeX_HEADER: \usetikzlibrary{shapes.geometric,arrows,decorations.pathmorphing,backgrounds,positioning,fit,petri}
:END:
#+BEGIN_LaTeX
%\logo{\includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/NSO_logo_small.pdf}~%
%    \includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}%
%}

\vspace{220pt}
\beamertemplatenavigationsymbolsempty
\setbeamertemplate{caption}[numbered]
\setbeamerfont{caption}{size=\tiny}
% \addtobeamertemplate{frametitle}{}{%
% \begin{textblock*}{100mm}(.85\textwidth,-1cm)
% \includegraphics[height=1cm,width=2cm]{cat}
% \end{textblock*}}

\tikzstyle{chemical} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=none]
\tikzstyle{hardware} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=gray!30]
\tikzstyle{ms} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{msw} = [rectangle, rounded corners, text width=7em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{label} = [rectangle,text width=8em, minimum height=1em, text centered, draw=none, fill=none]
\tikzstyle{hl} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=red!30]
\tikzstyle{box} = [rectangle, rounded corners, text width=5em, minimum height=5em,text centered, draw=black, fill=none]
\tikzstyle{arrow} = [thick,->,>=stealth]
\tikzstyle{hl-arrow} = [ultra thick,->,>=stealth,draw=red]

#+END_LaTeX


* Introduction
** Sphingolipids

- found in all mammalian cell membranes
  - and plasma lipoproteins
- Structural role
- Modulate numerous biological functions
  - apoptosis

- named after the Sphinx because of their enigmatic nature...

** Sphingosine and Ceramide

- long chain sphingolipid base
- N-acylated by a variety of fatty acids
\centering
#+BEGIN_LaTeX
\definesubmol{x}{-[7,.3]-[1,.3]}
\definesubmol{y}{-[:+30,.3]=[:-30,.3]}
\definesubmol{a}{-[1,.3](=[2,.3]O)!x!x!x!x!x!x!x!x!x!x!x}
\chemfig{OH!x([2,.5]<HN)-[7,.3](-[6,.3]OH)-[1,.3]=[7,.3]-[1,.3]!x!x!x!x!x!x}
\chemfig{OH!x([2,.5]<HN!a)-[7,.3](-[6,.3]OH)-[1,.3]=[7,.3]-[1,.3]!x!x!x!x!x!x}
%%\chemfig{!b}
#+END_LaTeX


** Sphingolipid Structure


#+NAME: fig:structure
#+ATTR_LaTeX: :width \textwidth
file:./figures/Sphingolipids_general_structures.png



** Biosynthesis

*** ER
- condensation of serine and palmitoyl-CoA \to sphinganine
- N-acylation \to ceramide

*** Golgi
- stepwise addition of monosaccharides
  - sphingomyelin
  - glucosylceramide
  - glycosphingolipids
  - gangliosides

** Biosynthesis

\centering
#+ATTR_LaTeX: :width 0.6\textwidth
[[file:./figures/synthesis.png]]


* Disorders of Sphingolipid Synthesis

** Serine Palmitoyltransferase (Subunit 1 or 2) Deficiency

- Defect in first step of sphingolipid biosynthesis 
- Major cause of dominant Hereditary Sensory and Autonomic Neuropathies (HSAN1).
  - Late onset (2-4th decade)
  - peripheral sensory neuropathy
  - distal sensory loss
  - ulcerative mutatilations
  - hypohidrosis
  - there is a more severe early onset form
- Accumulation of sphingoid bases \to pathology
- mutations in serine palmitoyltransferase (SPCTLC1 or 2) alter
  substrate specificity
  - serine \to alanine and glycine
- Elevated plasma 1-deoxy-sphingamine, 1-deoxy-methyl-sphingamine, 1-deoxy-ceramindes
- Trial of serine supplementation

** Ceramide Synthases 1 and 2 

 - Six human ceramide synthases
   - tissue and acyl-CoA substrate specificity
   - Neurological CERS1 &2
     - CER1 :: Myoclonic epilepsy, cognitive decline
       - Decreased C18-ceramide in cultured fibroblasts
     - CER2 :: Myoclonic epilepsy
       - Decreased VLC-ceramide in cultured fibroblasts
   - Dermatologic CERS3
     - CER3 :: Ichthyosis
       - Lack of VLC-ceramides in skin and fibroblasts 


** Fatty Acid 2-Hydroxylase

- spastic paraplegia
  - fatty acid hydroxylase associated neurodegeneration (FAHN)
- 38 patients, most in present in childhood
- slowly progressing
  - spastic paraplegia
  - dysarthria
  - mild cognitive decline
  - dystonia

- Insufficiency production of 2-hydroxy-galactosphingolipids
  - required in myelin
  - increase with brain development

** GM3 Synthase Deficiency

- Autosomal recessive infantile-onset epilepsy
  - Amish epilepsy syndrome
- In first year \to generalized tonic-clonic seizures
  - profound developmental stagnation and regression
  - salt and pepper syndrome
    - hyper and hypo-pigmented skin maculae
    - facial dysmorphism scoliosis
    - intellectual disability
    - seizures
    - choreoathetosis
    - spasticity
    
- lack of GM3, GD3 and higher gangliosides, and increased
  lactosylceramide and Gb4 levels in plasma and cultured cells


** GM2/GD2 Synthase Deficiency

- Mutations of B4GALNT1
- SPG26, a slowly progressive complex hereditary spastic paraplegia
  with mild to moderate cognitive impairment.

- Cultured fibroblasts of patients have shown decreased GM2 levels
  with an increase of its precursor, GM3.

** Non-lysosomal β-Glucosidase Deficiency

- GBA2 is a membrane-associated protein localised at the ER and Golgi
  - hydrolyse glucosylceramide to ceramide and glucose.
- GBA2 is distinct from the lysosomal acid β-glucosidase GBA1 deficient in Gaucher disease
- hereditary (complex) spastic paraplegia locus SPG46.
- Starting in childhood marked spasticity in lower extremities with
  progressive gait disturbances
  - later, ataxia and other cerebellar signs

** Ceramide Synthase 3 and ULFA \omega-Hydroxylase

- ceramides in skin maintain skin barrier homeostasis, prevent water
  loss and protect against microbial infections
- Autosomal recessive congenital ichthyosis (ARCI) is a heterogeneous
  group of disorders of epidermal cornification
- 9 causative genes have been identified including CERS3 and CYP4F22 

- CERS3 :: ichthyosis
  - lack of ceramides with VLCFA in cultured fibroblasts
- CYP4F22 :: ichthyosis
  - lack of ceramides with ULCFA in cultured fibroblasts

** Classification

*** Primarily nervous system involvement
- Serine palmitoyltransferase - peripheral sensory neuropathy
- Ceramide synthase 1 - myoclonic epilepsy
- Ceramide synthase 2 - myoclonic epilepsy
- Fatty Acid 2-hydroxylase - SPG35
- Nonlysosomal β-Glucosidase - SPG46
- GM3 Synthase Deficiency - Amish infantile epilepsy
- GM2/GD2 Synthase Deficiency - SPG26


*** Primarily skin involvement
- Ceramide synthase 3 - Ichthyosis
- ULCFA \omega-hydrolase - Ichthyosis

** Next time

- Back to LSDs with Sphingolipidoses

